ClearTrial Launches Study Forecasting Service
ClearTrial, a provider of clinical trial software, recently launched its Study Costing and Optimization Service (SCOS), a product that combines ClearTrial’s existing trial management software with the consultation services of the company’s clinical services staff. ClearTrial said the new offering will give smaller biopharma companies more control over clinical trial costs, resources and timelines.
As part of the SCOS, ClearTrials provides a clinical services manager who works with a client’s internal clinical team to generate detailed cost, resource and timeline reports for multiple study scenarios. These scenarios enable the client to analyze different possible cost- and time-cutting measures.
"Many smaller biopharma companies lack the visibility to accurately forecast clinical trials, leading to them not understanding how much clinical trials should really cost, as well as dealing with unforeseen shifts in trial timelines," said Andrew Grygiel, vice president of marketing and product management, in a statement. “We conducted an extensive pilot program of the ClearTrial Study Costing and Optimization Service, and, in every case, were able to identify dramatic reductions in study costs and timelines, while ensuring that the studies were still achievable."
Upcoming Events
-
23May
-
21Oct